NASDAQ:TCDA Tricida (TCDA) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free TCDA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.11▼$0.1952-Week Range N/AVolume31.13 million shsAverage Volume17.62 million shsMarket Capitalization$6.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tricida alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Tricida Stock (NASDAQ:TCDA)Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. TCDA Stock News HeadlinesFebruary 6, 2024 | finance.yahoo.comSierraConstellation Partners Receives Industry Recognition for Work with TricidaJanuary 13, 2024 | es.investing.comTricida Inc (TCDAQ)April 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. February 14, 2023 | finance.yahoo.comTricida, Inc. (TCDA) Stock Historical Prices & Data - Yahoo FinanceFebruary 3, 2023 | wsj.comFirm Retention Summary: Tricida Inc.November 15, 2022 | finance.yahoo.comTricida Announces Third Quarter 2022 Financial ResultsNovember 2, 2022 | finance.yahoo.comTricida Provides Strategic UpdateOctober 25, 2022 | markets.businessinsider.comWhy Tricida Stock Is Tanking TodayApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. October 25, 2022 | bizjournals.comFailed trial sends Peninsula kidney drug company's stock tumbling 94%October 25, 2022 | msn.comThis Biotech Lost 95% in a Single Day. It Still Deserves CreditOctober 25, 2022 | finance.yahoo.comTricida Shares Nosedive After Disappointing Data From Much Anticipated Kidney Disease TrialOctober 24, 2022 | investorplace.comWhy Is Tricida (TCDA) Stock Down 90% Today?October 24, 2022 | finance.yahoo.comTricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of VeverimerOctober 19, 2022 | seekingalpha.comTricida announces $125M debt facility - Seeking AlphaOctober 19, 2022 | seekingalpha.comTricida enters $125M debt facility (NASDAQ:TCDA) - Seeking AlphaOctober 19, 2022 | benzinga.comTricida Whale Trades For October 19 - Tricida (NASDAQ:TCDA) - BenzingaOctober 19, 2022 | businesswire.comTricida Announces $125 Million Debt Facility with Hercules Capital - Business WireOctober 18, 2022 | benzinga.com$2 Million Bet On Tricida? 3 Stocks Insiders Are Buying - Tricida (NASDAQ:TCDA), Riley Exploration Permia - BenzingaOctober 14, 2022 | businesswire.comSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Tricida, Inc. (TCDA) and Encourages Long-Term TCDA Stockholders to Contact the Firm - Business WireOctober 13, 2022 | stockhouse.com2022-10-13 | NDAQ:TCDA | Press Release | Tricida Inc. - StockhouseOctober 13, 2022 | benzinga.comSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Tricida, Inc. (TCDA) and Encourages Long-Te - BenzingaOctober 7, 2022 | benzinga.comTricida Whale Trades SpottedOctober 4, 2022 | uk.investing.com$17 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying By Benzinga - Investing.com UKOctober 3, 2022 | finance.yahoo.comTricida Announces the Selection of the VALOR-CKD Trial for an Oral Presentation in the High-Impact Clinical Trials Session at ASN Kidney Week 2022October 3, 2022 | businesswire.comTricida Announces the Selection of the VALOR-CKD Trial for an Oral Presentation in the High-Impact Clinical Trials Session at ASN Kidney Week 2022 - Business WireSeptember 29, 2022 | uk.investing.comOver $352 Million Bet On Occidental Petroleum? 3 Stocks Insiders Are Buying By Benzinga - Investing.com UKSee More Headlines Receive TCDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tricida and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2021Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:TCDA CUSIPN/A CIK1595585 Webwww.tricida.com Phone(415) 429-7800FaxN/AEmployees57Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-176,570,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-103.81% Debt Debt-to-Equity RatioN/A Current Ratio4.87 Quick Ratio4.87 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares55,670,000Free Float35,851,000Market Cap$6.01 million OptionableNot Optionable Beta0.22 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesGerrit KlaernerPresident, Chief Executive Officer & DirectorGeoffrey M. ParkerChief Operating & Financial Officer, Executive VPDawn ParsellExecutive Vice President-Clinical DevelopmentRobert McKagueChief Compliance Officer, EVP & General CounselAnnie YoshiyamaChief Accounting Officer & Vice President-FinanceKey CompetitorsProtagenic TherapeuticsNASDAQ:PTIXHoth TherapeuticsNASDAQ:HOTHFirst Wave BioPharmaNASDAQ:FWBIVaccinexNASDAQ:VCNXXenetic BiosciencesNASDAQ:XBIOView All Competitors TCDA Stock Analysis - Frequently Asked Questions How were Tricida's earnings last quarter? Tricida, Inc. (NASDAQ:TCDA) issued its quarterly earnings data on Monday, November, 8th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.70) by $0.09. During the same quarter in the previous year, the company earned ($1.55) EPS. What is Gerrit Klaerner's approval rating as Tricida's CEO? 2 employees have rated Tricida Chief Executive Officer Gerrit Klaerner on Glassdoor.com. Gerrit Klaerner has an approval rating of 100% among the company's employees. This puts Gerrit Klaerner in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Tricida own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tricida investors own include Pfizer (PFE), Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), Dynavax Technologies (DVAX), VBI Vaccines (VBIV), Aldeyra Therapeutics (ALDX), Atara Biotherapeutics (ATRA), bluebird bio (BLUE), Moderna (MRNA) and AT&T (T). When did Tricida IPO? Tricida (TCDA) raised $175 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO. This page (NASDAQ:TCDA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tricida, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
